En español
NIDA

Menu

Meetings & Events

Adolescent Drug Abuse Screening in General Medical Settings: Resources for Clinicians

Details

Location: Rockville, Maryland, Neuroscience Center
Date: May 27, 2010 (All day)

Contact

Ericka Boone , boonee@nida.nih.gov

Summary

NIDA Planning Group
Gaya Dowling
Ericka Boone
Wilson Compton
Redonna Chandler
Richard Denisco
Jacqueline Lloyd
Geetha Subramaniam
Petra Jacobs

Meeting Goals/Objectives

  • Expectations from Meeting
    • To discuss the current state of the science and the most effective approaches for adolescent screening in primary care settings
    • To inform NIDA’s development of an electronic adolescent drug screening tool and resource guide for clinicians.
  • Why important?
    • The high prevalence of substance abuse among adolescents calls for targeted effective intervention strategies.
    • Primary care settings provide a unique opportunity to identify substance youth and prevent their escalation to addiction or refer them to necessary treatment

Topics Discussed

  • Validated adolescent screening instruments
  • Considerations for different ages/developmental stages
  • Key decision points when selecting or creating a screener (e.g., purpose of the screener, risk versus severity, cut points, etc.)
  • Clinical decision support
  • What do physician’s do when a screening is positive
  • Use of technology in adolescent screening tools

Take Home Messages from Talks/Group Discussions

Outcomes from Discussion

  • Two primary evidence-based instruments discussed – CRAFFT and GAIN
  • Pros and cons of embedding drug abuse screening in broader behavioral health care screening
  • Different questions , cut-points, item hierarchies for different adolescent stages
  • Research on brief intervention for teens ongoing – Bernstein paper only published study
  • Incorporation of technology in screener is key, but technology changes quickly
  • Screening for prescription drug abuse calls for different approach – no one has studied yet
  • American Academy of Pediatrics will be releasing a policy statement on SBI using CRAFFT and brief advice at the end of summer
  • NIAAA will be releasing their adolescent screen at the end of the summer – not based on CRAFFT

Future Directions

  • Research
    • Validation of CRAFFT prescreen
    • SBI for prescription drug abuse
    • Long-term trajectories for kids who screen positive on existing screens – for USPSTF
  • NIDA adolescent screen???

    Contact Press Office

    301-443-6245 (8:30 - 5:30 ET)
    media@nida.nih.gov